Citation Impact
Citing Papers
Topical Ocular Drug Delivery: Recent Developments and Future Challenges
1986
Stacking complexation by nicotinamide: A useful way of enhancing drug solubility
2006
Cyclodextrins as pharmaceutical solubilizers
2007 Standout
Why gold nanoparticles are more precious than pretty gold: Noble metal surface plasmon resonance and its enhancement of the radiative and nonradiative properties of nanocrystals of different shapes
2005 Standout
In vitro and in vivo evaluations of topically applied capsaicin and nonivamide from hydrogels
2001
The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status
2020 Standout
Instability, stabilization, and formulation of liquid protein pharmaceuticals
1999 Standout
A review of implantable intravitreal drug delivery technologies for the treatment of posterior segment eye diseases
2009
Ocular Drug Delivery
2010 Standout
Amorphous pharmaceutical solids: preparation, characterization and stabilization
2001 Standout
Rapid translocation of nanoparticles from the lung airspaces to the body
2010 StandoutNobel
Advances in Surface-Enhanced Fluorescence
2004
Hydrogel nanoparticles in drug delivery
2008 Standout
Ganciclovir
2018
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
2015 Standout
Solid‐state chemical stability of proteins and peptides
1999
Interactions of Trimeric Purine Nucleoside Phosphorylases with Ground State Analogues—Calorimetric and Fluorimetric Studies
2003 StandoutNobel
Pharmaceutical Applications of Cyclodextrins. 2. In Vivo Drug Delivery
1996
Cyclodextrin-based pharmaceutics: past, present and future
2004 Standout
Targeting the Achilles heel of the hepatitis B virus: a review of current treatments against covalently closed circular DNA
2015 StandoutNobel
Improving protein therapeutics with sustained-release formulations
1998
Polyionic hydrocolloids for the intestinal delivery of protein drugs: Alginate and chitosan — a review
2006 Standout
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Ionic-Liquid-Mediated Extraction and Separation Processes for Bioactive Compounds: Past, Present, and Future Trends
2017 Standout
Simultaneous determination of guanine and adenine in DNA using an electrochemically pretreated glassy carbon electrode
2002
Supramolecular Chirality in Self-Assembled Systems
2015 Standout
Application of Ionic Liquid to Polymorphic Design of Pharmaceutical Ingredients
2010
Cyclodextrin Drug Carrier Systems
1998 Standout
Anisotropic Metal Nanoparticles: Synthesis, Assembly, and Optical Applications
2005 Standout
Nanostructured Plasmonic Sensors
2008 Standout
Solubility Advantage of Pharmaceutical Cocrystals
2009 Standout
Ocular absorption following topical delivery
1995
Advanced Carbon Electrode Materials for Molecular Electrochemistry
2008 Standout
Prodrugs for improved ocular drug delivery
1989
Inhibitory Effect of Adefovir on Viral DNA Synthesis and Covalently Closed Circular DNA Formation in Duck Hepatitis B Virus-Infected Hepatocytes In Vivo and In Vitro
2002
Cyclodextrins and their uses: a review
2003 Standout
Chitosan Chemistry and Pharmaceutical Perspectives
2004 Standout
Corneal surface glycosylation is modulated by IL‐1R and Pseudomonas aeruginosa challenge but is insufficient for inhibiting bacterial binding
2017 StandoutNobel
Dynamically Analyte-Responsive Macrocyclic Host–Fluorophore Systems
2014
Structure−Antiviral Activity Relationship in the Series of Pyrimidine and Purine N-[2-(2-Phosphonomethoxy)ethyl] Nucleotide Analogues. 1. Derivatives Substituted at the Carbon Atoms of the Base
1999
Design of a superior cytokine antagonist for topical ophthalmic use
2013
Works of Gary C. Visor being referenced
Oral Formulations of Adefovir Dipivoxil: In Vitro Dissolution and in Vivo Bioavailability in Dogs
1997
Stability of Interleukin 1β (IL-1β) in Aqueous Solution: Analytical Methods, Kinetics, Products, and Solution Formulation Implications
1991
Oral Bioavailability of the Antiretroviral Agent 9-(2-phosphonylmethoxyethyl)adenine (PMEA) from Three Formulations of the Prodrug Bis(pivaloyloxymethyl)-PMEA in Fasted Male Cynomolgus Monkeys
1994
Optimization ofin VitroFlux Through Hairless Mouse Skin of Cidofovir, a Potent Nucleotide Analog
1995
An Unexpected pH Effect on the Stability of Moexipril Lyophilized Powder
1989
Stability of ganciclovir sodium (DHPG sodium) in 5% dextrose or 0.9% sodium chloride injections
1986
Reverse-Phase HPLC Analysis of the Antiviral Drug, 9-[1,3-Dihydroxy-2-Propoxy Methyl] -Guanine (DHPG), with Amperometric Detection
1985
Drug design strategies for ocular therapeutics
1994
Fluorescence Immunoassay
1981
Formation of adrenaline in the iris-ciliary body from adrenalone diesters
1984
Electrochemistry of Purine Derivatives 2: Correlation of Anodic Differential Pulse Peak Potentials with Hammett Substituent Constants
1985
Water Soluble Complexes of the Antiviral Drugs, 9-[(1,3-Dihydroxy-2-propoxy)Methyl]guanine and Acyclovir: The Role of Hydrophobicity in Complex Formation
1986